期刊
MOLECULAR NUTRITION & FOOD RESEARCH
卷 62, 期 1, 页码 -出版社
WILEY
DOI: 10.1002/mnfr.201700483
关键词
(-)-epigallocatechin-3-gallate; catechins; fatty liver; nonalcoholic fatty liver disease(NAFLD); nonalcoholic steatohepatitis (NASH)
资金
- National Natural Science Foundation of China [81573668, 81374031, 81673765]
Nonalcoholic fatty liver disease (NAFLD) is a major health issue throughout the world. However, no validated treatments for NAFLD are currently available. In-depth studies have demonstrated the efficacy of (-)-epigallocatechin-3-gallate (EGCG), a main bioactive chemical extracted from green tea, in treating NAFLD. EGCG exhibits multi-pronged preventive and therapeutic activities, including promoting lipid and glucose metabolism, anti-lipid peroxidation and anti-inflammation activities, anti-fibrosis, and anti-NAFLD related tumor, thus contributing to the mitigation of NAFLD occurrence and progression. The objectives of this paper are to review and discuss the currently known targets, signaling pathways and roles of EGCG that interfere with NAFLD pathogenesis, then providing additional experimental evidence and the foundation for the further studies and clinical applications of EGCG in the prevention and treatment of NAFLD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据